PUBLICATIONS · 19720927
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Oct 1
- First author
- Friedman HS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2010 Apr 20;28(12):e188-9; author reply e190-2. doi: 10.1200/JCO.2009.26.9027.
- note
- Source null
- related pmid
- 20159801
- relationship
- Comment in
- citation
- J Clin Oncol. 2023 Nov 10;41(32):4945-4952. doi: 10.1200/JCO.22.02772.
- note
- Source null
- related pmid
- 37935104
- relationship
- Republished in
Authors and identifiers
- name
- Friedman HS
- type
- Author
- name
- Prados MD
- type
- Author
- name
- Wen PY
- type
- Author
- name
- Mikkelsen T
- type
- Author
- name
- Schiff D
- type
- Author
- name
- Abrey LE
- type
- Author
- name
- Yung WK
- type
- Author
- name
- Paleologos N
- type
- Author
- name
- Nicholas MK
- type
- Author
- name
- Jensen R
- type
- Author
- name
- Vredenburgh J
- type
- Author
- name
- Huang J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Friedman HS
- type
- Author
- name
- Prados MD
- type
- Author
- name
- Wen PY
- type
- Author
- name
- Mikkelsen T
- type
- Author
- name
- Schiff D
- type
- Author
- name
- Abrey LE
- type
- Author
- name
- Yung WK
- type
- Author
- name
- Paleologos N
- type
- Author
- name
- Nicholas MK
- type
- Author
- name
- Jensen R
- type
- Author
- name
- Vredenburgh J
- type
- Author
- name
- Huang J
- type
- Author
- bibliography ids
- nci-bib-81c0844f23956fa2879bc91e
- book metadata
- content sha256
- 67860ce3e2668b7e5f683d31f94db6fef70e1f2bda5827d175f41bc07ee716d4
- document type
- citation
- dois
- 10.1200/JCO.2008.19.8721
- electronic publication date
- display
- 2009 Aug 31
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19720927
- immutable id
- pubmed:19720927@67860ce3e2668b7e5f683d31f94db6fef70e1f2bda5827d175f41bc07ee716d4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 28
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4733-40
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2010 Apr 20;28(12):e188-9; author reply e190-2. doi: 10.1200/JCO.2009.26.9027.
- note
- Source null
- related pmid
- 20159801
- relationship
- Comment in
- citation
- J Clin Oncol. 2023 Nov 10;41(32):4945-4952. doi: 10.1200/JCO.22.02772.
- note
- Source null
- related pmid
- 37935104
- relationship
- Republished in
- outcomes validated
- false
- pmid
- 19720927
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 9ac768f9eb32c8422510cade3e12334254100b39ac886ca80ecae4ac32d0980e
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Oct 1
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Preserved source evidence · Not medical advice
Triangle